BioSpace News Archive

Biotech Bay

GE HealthCare Announces Study Results Demonstrating Portrait Mobile Continuous Monitoring Solution Performance with Patients and Care Teams in the Ward

GE HealthCare announced new data from a pilot study conducted with Cleveland Clinic evaluating the Portrait Mobile wireless and wearable monitoring solution.

October 15, 2023
·
6 min read
ImCheck to Present New Positive Data on ICT01 Monotherapy in Hematological Cancers at ESMO 2023

ImCheck Therapeutics announced that updated data from its ongoing Phase I/IIa clinical trial EVICTION will be presented at the European Society for Medical Oncology Congress in an oral session on October 22nd in Madrid.

October 15, 2023
·
7 min read
Bio NC

Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentation at ESMO Congress 2023

Arvinas, Inc. and Pfizer Inc. announced they will present updated Phase 1/2 data for vepdegestrant at the 2023 European Society for Medical Oncology Annual Congress.

October 15, 2023
·
8 min read
Novocure Announces Presence at European Society for Medical Oncology (ESMO) Congress 2023

Novocure announced its participation in the European Society for Medical Oncology Congress 2023 from October 20 – 24 in Madrid.

October 15, 2023
·
6 min read
Pharm Country

Arvinas Announces Upcoming Bavdegalutamide Poster Presentation at ESMO Congress 2023

Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, announced it will present updated Phase 1/2 trial data for bavdegalutamide at the 2023 European Society for Medical Oncology Annual Congress.

October 15, 2023
·
3 min read
CatalYm Presents Data at ESMO 2023 Expanding GDF-15’s Role in Checkpoint Therapy Resistance by Inhibition of Myeloid Immune Cell Activation

CatalYm announced new preclinical data expanding the mechanistic understanding of how GDF-15 plays a key role in cancer therapy resistance.

October 15, 2023
·
4 min read
Bio NC

Astellas to Share New Data Across Hard-to-Treat Cancers During ESMO Congress 2023

Astellas Pharma Inc. will share new research results during the European Society for Medical Oncology Congress 2023 from October 20-24, showcasing the company’s focus on making a meaningful difference for people living with hard-to-treat cancers.

October 15, 2023
·
8 min read
MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa

MoonLake Immunotherapeutics (“MoonLake”; Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases

October 15, 2023
·
14 min read
BioMidwest

AbbVie’s SKYRIZI® (risankizumab) Versus STELARA® (ustekinumab) Head-to-Head Study in Crohn’s Disease Meets All Primary and Secondary Endpoints

AbbVie presented positive results from the head-to-head Phase 3 SEQUENCE study that evaluated the efficacy and safety of risankizumab compared to ustekinumab in patients with moderately to severely active Crohn’s disease who have failed one or more anti-TNFs.1 The data were presented at the United European Gastroenterology Week 2023, October 14-17.

October 15, 2023
·
15 min read
Genetown

Precede Biosciences Announces First Scientific Data from its Liquid Biopsy Platform to be Presented as an Oral Presentation at ESMO 2023

Precede Biosciences, a company impacting the development and use of precision medicines with a first-in-class liquid biopsy platform, advances its mission with a first release of groundbreaking scientific data at the European Society for Medical Oncology Congress 2023.

October 15, 2023
·
2 min read